Ann Childress

4.0k total citations · 1 hit paper
163 papers, 2.9k citations indexed

About

Ann Childress is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Ann Childress has authored 163 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Psychiatry and Mental health, 43 papers in Cognitive Neuroscience and 30 papers in Clinical Psychology. Recurrent topics in Ann Childress's work include Attention Deficit Hyperactivity Disorder (158 papers), Bipolar Disorder and Treatment (61 papers) and Child and Adolescent Psychosocial and Emotional Development (27 papers). Ann Childress is often cited by papers focused on Attention Deficit Hyperactivity Disorder (158 papers), Bipolar Disorder and Treatment (61 papers) and Child and Adolescent Psychosocial and Emotional Development (27 papers). Ann Childress collaborates with scholars based in United States, Canada and United Kingdom. Ann Childress's co-authors include Sharon B. Wigal, Floyd R. Sallee, Frank A. López, Scott H. Kollins, Susan A. Berry, Andrew J. Cutler, Jeffrey H. Newcorn, Matthew Brams, Timothy D. Brewerton and Mark P. Jarrell and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Biological Psychiatry.

In The Last Decade

Ann Childress

154 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder – implications for clinical recognition and intervention

2018 239 citations Stephen V. Faraone, Ann Childress et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Childress United States	29	2.4k	945	760	453	310	163	2.9k
Charles D. Casat United States	24	2.0k 0.8×	851 0.9×	1.1k 1.5×	375 0.8×	249 0.8×	37	2.7k
Adelaide S. Robb United States	24	1.6k 0.6×	437 0.5×	989 1.3×	107 0.2×	269 0.9×	74	2.2k
Sharon B. Wigal United States	38	3.6k 1.5×	1.5k 1.6×	968 1.3×	976 2.2×	546 1.8×	108	4.1k
F.R. Sallee United States	22	1.6k 0.7×	1000 1.1×	1.4k 1.8×	253 0.6×	229 0.7×	39	2.8k
L. Eugene Arnold United States	23	1.7k 0.7×	1.2k 1.3×	1.1k 1.4×	484 1.1×	218 0.7×	66	2.4k
Peter M. Wehmeier Germany	21	1.1k 0.5×	370 0.4×	594 0.8×	149 0.3×	122 0.4×	36	1.7k
Marsha D. Rappley United States	13	1.1k 0.4×	517 0.5×	385 0.5×	259 0.6×	152 0.5×	24	1.5k
Christian Fleischhaker Germany	26	969 0.4×	338 0.4×	982 1.3×	65 0.1×	122 0.4×	83	1.8k
L. Cinnamon Bidwell United States	30	666 0.3×	669 0.7×	395 0.5×	92 0.2×	257 0.8×	100	2.3k
Covadonga M. Díaz‐Caneja Spain	24	1.1k 0.4×	447 0.5×	749 1.0×	56 0.1×	100 0.3×	95	2.2k

Countries citing papers authored by Ann Childress

Since Specialization

Citations

This map shows the geographic impact of Ann Childress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Childress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Childress more than expected).

Fields of papers citing papers by Ann Childress

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Childress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Childress. The network helps show where Ann Childress may publish in the future.

Co-authorship network of co-authors of Ann Childress

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Childress. A scholar is included among the top collaborators of Ann Childress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Childress. Ann Childress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilens, Timothy E., et al.. (2025). Efficacy and Safety of Centanafadine for ADHD Treatment in Children: A Randomized Clinical Trial. 1(3). 1–11. 1 indexed citations

Childress, Ann, et al.. (2025). Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical Trial. Journal of the American Academy of Child & Adolescent Psychiatry.

Childress, Ann, et al.. (2025). Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label Trial. Journal of Child and Adolescent Psychopharmacology. 35(3). 155–166. 1 indexed citations

Schein, Jeffrey, et al.. (2024). Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study in the United States. BMC Psychiatry. 24(1). 618–618. 3 indexed citations

Schein, Jeff, et al.. (2024). Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release. Journal of Managed Care & Specialty Pharmacy. 30(6). 528–540. 5 indexed citations

Schein, Jeff, et al.. (2024). A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of Comparative Effectiveness Research. 13(9). e240089–e240089.

Schein, Jeffrey, et al.. (2024). PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment. Value in Health. 27(6). S310–S310. 1 indexed citations

Schein, Jeff, et al.. (2024). Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of Medical Economics. 27(1). 653–662.

Schein, Jeff, et al.. (2024). Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment. Patient Preference and Adherence. Volume 18. 1651–1664. 3 indexed citations

10.

Baweja, Raman, Stephen V. Faraone, Ann Childress, et al.. (2024). From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of Child and Adolescent Psychopharmacology. 34(4). 167–182. 6 indexed citations

11.

Schein, Jeff, et al.. (2024). Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers. Journal of Child and Adolescent Psychopharmacology. 35(1). 49–60.

12.

Childress, Ann, et al.. (2023). Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. Journal of Child and Adolescent Psychopharmacology. 33(2). 51–58. 5 indexed citations

13.

Childress, Ann, et al.. (2023). Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate. Journal of Child and Adolescent Psychopharmacology. 33(4). 134–142. 2 indexed citations

14.

Schein, Jeff, et al.. (2022). Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in Therapy. 39(12). 5487–5503. 9 indexed citations

15.

Childress, Ann, et al.. (2020). Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 30(10). 580–589. 14 indexed citations

16.

Childress, Ann & Jeffrey G. Stark. (2018). Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children. Journal of Child and Adolescent Psychopharmacology. 28(9). 606–614. 22 indexed citations

17.

Childress, Ann, et al.. (2017). Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 28(1). 10–18. 22 indexed citations

18.

Childress, Ann, et al.. (2016). A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 26(6). 505–512. 16 indexed citations

19.

Findling, Robert L., Andrew J. Cutler, Keith E. Saylor, et al.. (2013). A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 23(1). 11–21. 33 indexed citations

20.

Silva, Raul, Rafael Muniz, Linda Pestreich, et al.. (2005). Efficacy of Two Long-Acting Methylphenidate Formulations in Children with Attention- Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting. Journal of Child and Adolescent Psychopharmacology. 15(4). 637–654. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact